{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:27:57Z","timestamp":1774524477143,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Beijing Public Health Experts Project","award":["G2023-2-002"],"award-info":[{"award-number":["G2023-2-002"]}]},{"name":"Beijing Yangfan 3.0 Diagnosis and Treatment Improvement Project","award":["ZLRK202331"],"award-info":[{"award-number":["ZLRK202331"]}]},{"name":"Beijing Tongzhou District Science and Technology Plan Program","award":["WS2023064"],"award-info":[{"award-number":["WS2023064"]}]},{"name":"Beijing Tongzhou District Science and Technology Innovation Talent Funding Program","award":["JCQN2024013"],"award-info":[{"award-number":["JCQN2024013"]}]},{"name":"Open Subjects for the Training Fund of the School of Clinical Specialties (Department) of Capital Medical University","award":["CCMU2024ZKYXY011"],"award-info":[{"award-number":["CCMU2024ZKYXY011"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The co-resistance between bedaquiline and clofazimine raises significant concerns, as they are commonly co-administered as core drugs in drug-resistant TB regimens. The present study aimed to monitor drug resistance-associated gene mutations and the phenotypic change in Mycobacterium tuberculosis (Mtb) under a stepwise drug resistance induction in vitro using bedaquiline, clofazimine or combined drugs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Drug-resistant Mtb strains were gradually induced in vitro on a drug-containing solid medium with a 2-fold increasing concentration of bedaquiline, clofazimine and their combination. The MIC of the induced drug-resistant Mtb strains was determined. The drug resistance-associated genes, including Rv0678, Rv1979c, atpE and pepQ, were sequenced and analysed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Unlike exposure to bedaquiline alone or the combination of these two drugs, clofazimine alone resulted in drug resistance gene mutations occurring later, specifically in the fourth round of induction as opposed to the second round of induction. Besides, nucleotide deletion or insertion in Rv0678 was the main mutation type for induction under the two-drug combination, while single-nucleotide polymorphisms (SNPs) in Rv0678 were the major mutation types when induced by bedaquiline or clofazimine alone. Rv0678 mutation happened at a relatively lower bedaquiline concentration exposure alone, while atpE mutation occurred at a higher bedaquiline concentration. Regardless of the drug exposure manner, a strong correlation between bedaquiline MICs and clofazimine MICs was observed in all drug resistance strains.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Combined exposure to bedaquiline and clofazimine developed Rv0678 mutation as early as exposure to bedaquiline alone. However, rather than SNPs, deletion and insertion were the dominant mutation types in dual-drug exposure strain.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkae405","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T04:58:44Z","timestamp":1731301124000},"page":"262-269","source":"Crossref","is-referenced-by-count":2,"title":["<i>In vitro<\/i> monitoring of drug resistance emergence during stepwise induction of bedaquiline and clofazimine, alone and in combination: a phenotypic and genotypic analysis"],"prefix":"10.1093","volume":"80","author":[{"given":"Suting","family":"Chen","sequence":"first","affiliation":[{"name":"National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Shang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Beijing Friendship Hospital, Capital Medical University , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jifang","family":"Zheng","sequence":"additional","affiliation":[{"name":"National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengmin","family":"Huo","sequence":"additional","affiliation":[{"name":"National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xue","sequence":"additional","affiliation":[{"name":"National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Zhao","sequence":"additional","affiliation":[{"name":"National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanglu","family":"Jiang","sequence":"additional","affiliation":[{"name":"National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naihui","family":"Chu","sequence":"additional","affiliation":[{"name":"Tuberculosis Department, Beijing Chest Hospital, Capital Medical University , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4295-4262","authenticated-orcid":false,"given":"Hairong","family":"Huang","sequence":"additional","affiliation":[{"name":"National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"2025010309474865500_dkae405-B1","volume-title":"Global Tuberculosis Report","author":"WHO","year":"2023"},{"key":"2025010309474865500_dkae405-B2","volume-title":"Global Tuberculosis Report","author":"WHO","year":"2019"},{"key":"2025010309474865500_dkae405-B3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nchembio884","article-title":"Diarylquinolines target subunit c of mycobacterial ATP synthase","volume":"3","author":"Koul","year":"2007","journal-title":"Nat Chem Biol"},{"key":"2025010309474865500_dkae405-B4","doi-asserted-by":"publisher","first-page":"e1500106","DOI":"10.1126\/sciadv.1500106","article-title":"Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline","volume":"1","author":"Preiss","year":"2015","journal-title":"Sci Adv"},{"key":"2025010309474865500_dkae405-B5","volume-title":"WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment","author":"WHO","year":"2019"},{"key":"2025010309474865500_dkae405-B6","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S1473-3099(19)30489-X","article-title":"BPaL approved for multidrug-resistant tuberculosis","volume":"19","author":"Burki","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2025010309474865500_dkae405-B7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N Engl J Med"},{"key":"2025010309474865500_dkae405-B8","volume-title":"WHO Consolidated Guidelines on Tuberculosis: Module 4: Treatment\u2014Drug-Susceptible Tuberculosis Treatment","author":"WHO","year":"2022"},{"key":"2025010309474865500_dkae405-B9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"2025010309474865500_dkae405-B10","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1128\/AAC.01611-09","article-title":"Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor","volume":"54","author":"Huitric","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309474865500_dkae405-B11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tube.2008.08.003","article-title":"Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system","volume":"89","author":"Milano","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"key":"2025010309474865500_dkae405-B12","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1128\/AAC.00753-16","article-title":"Mutations in pepQ confer low-level resistance to bedaquiline and clofazimine in Mycobacterium tuberculosis","volume":"60","author":"Almeida","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309474865500_dkae405-B13","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1164\/rccm.201001-0077OC","article-title":"Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis","volume":"182","author":"Van Deun","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2025010309474865500_dkae405-B14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.cmi.2018.07.012","article-title":"Clofazimine improves clinical outcomes in multidrug-resistant tuberculosis: a randomized controlled trial","volume":"25","author":"Duan","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2025010309474865500_dkae405-B15","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1183\/09031936.00142914","article-title":"A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment","volume":"45","author":"Somoskovi","year":"2015","journal-title":"Eur Respir J"},{"key":"2025010309474865500_dkae405-B16","doi-asserted-by":"publisher","first-page":"12393","DOI":"10.1038\/ncomms12393","article-title":"Turning the respiratory flexibility of Mycobacterium tuberculosis against itself","volume":"7","author":"Lamprecht","year":"2016","journal-title":"Nat Commun"},{"key":"2025010309474865500_dkae405-B17","doi-asserted-by":"publisher","first-page":"10276","DOI":"10.1074\/jbc.M110.200501","article-title":"Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species","volume":"286","author":"Yano","year":"2011","journal-title":"J Biol Chem"},{"key":"2025010309474865500_dkae405-B18","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.biopha.2018.06.023","article-title":"Clofazimine: a useful antibiotic for drug-resistant tuberculosis","volume":"105","author":"Mirnejad","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"2025010309474865500_dkae405-B19","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1093\/jac\/dkw244","article-title":"Activation of type II NADH dehydrogenase by quinolinequinones mediates antitubercular cell death","volume":"71","author":"Heikal","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2025010309474865500_dkae405-B20","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1093\/jac\/dkv150","article-title":"Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis","volume":"70","author":"Zhang","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2025010309474865500_dkae405-B21","doi-asserted-by":"publisher","first-page":"e00239-17","DOI":"10.1128\/AAC.00239-17","article-title":"Primary clofazimine and bedaquiline resistance among isolates from patients with multidrug-resistant tuberculosis","volume":"61","author":"Xu","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309474865500_dkae405-B22","doi-asserted-by":"publisher","first-page":"106509","DOI":"10.1016\/j.ijantimicag.2021.106509","article-title":"Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid","volume":"59","author":"Kim","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"2025010309474865500_dkae405-B23","first-page":"M24-A2","volume-title":"Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes","author":"Woods","year":"2011","edition":"2nd ed."},{"key":"2025010309474865500_dkae405-B24","volume-title":"Optimized Broth Microdilution Plate Methodology for Drug Susceptibility Testing of Mycobacterium tuberculosis Complex","author":"WHO","year":"2022"},{"key":"2025010309474865500_dkae405-B25","doi-asserted-by":"publisher","first-page":"2200239","DOI":"10.1183\/13993003.00239-2022","article-title":"Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis","volume":"60","author":"Consortium","year":"2022","journal-title":"Eur Respir J"},{"key":"2025010309474865500_dkae405-B26","doi-asserted-by":"publisher","first-page":"e01677-19","DOI":"10.1128\/JCM.01677-19","article-title":"Validation of bedaquiline phenotypic drug susceptibility testing methods and breakpoints: a multilaboratory, multicountry study","volume":"58","author":"Kaniga","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2025010309474865500_dkae405-B27","doi-asserted-by":"publisher","first-page":"e0291920","DOI":"10.1128\/JCM.02919-20","article-title":"Bedaquiline drug resistance emergence assessment in multidrug-resistant tuberculosis (MDR-TB): a 5-year prospective in vitro surveillance study of bedaquiline and other second-line drug susceptibility testing in MDR-TB isolates","volume":"60","author":"Kaniga","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2025010309474865500_dkae405-B28","doi-asserted-by":"publisher","first-page":"e00479-20","DOI":"10.1128\/AAC.00479-20","article-title":"A multimethod, multicountry evaluation of breakpoints for bedaquiline resistance determination","volume":"64","author":"Ismail","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309474865500_dkae405-B29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/jac\/dkw417","article-title":"Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo","volume":"72","author":"Ammerman","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2025010309474865500_dkae405-B30","doi-asserted-by":"publisher","first-page":"e1002158","DOI":"10.1371\/journal.ppat.1002158","article-title":"Selection of resistant bacteria at very low antibiotic concentrations","volume":"7","author":"Gullberg","year":"2011","journal-title":"PLoS Pathog"},{"key":"2025010309474865500_dkae405-B31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12879-021-06024-8","article-title":"Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China","volume":"21","author":"Zheng","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2025010309474865500_dkae405-B32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ebiom.2018.01.005","article-title":"Defining bedaquiline susceptibility, resistance, cross-resistance and associated genetic determinants: a retrospective cohort study","volume":"28","author":"Ismail","year":"2018","journal-title":"EBioMedicine"},{"key":"2025010309474865500_dkae405-B33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cmi.2020.08.030","article-title":"Frequent acquisition of bedaquiline resistance by epidemic extensively drug-resistant Mycobacterium tuberculosis strains in Russia during long-term treatment","volume":"27","author":"Mokrousov","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2025010309474865500_dkae405-B34","doi-asserted-by":"publisher","first-page":"e102135","DOI":"10.1371\/journal.pone.0102135","article-title":"Acquired resistance of Mycobacterium tuberculosis to bedaquiline","volume":"9","author":"Andries","year":"2014","journal-title":"PLoS One"},{"key":"2025010309474865500_dkae405-B35","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1128\/AAC.00037-14","article-title":"Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosis","volume":"58","author":"Hartkoorn","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309474865500_dkae405-B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mimet.2018.08.011","article-title":"In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants","volume":"153","author":"Ismail","year":"2018","journal-title":"J Microbiol Methods"},{"key":"2025010309474865500_dkae405-B37","doi-asserted-by":"publisher","first-page":"807095","DOI":"10.3389\/fcimb.2022.807095","article-title":"Whole genome sequencing identifies novel mutations associated with bedaquiline resistance in Mycobacterium tuberculosis","volume":"12","author":"Guo","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2025010309474865500_dkae405-B38","doi-asserted-by":"publisher","first-page":"e604","DOI":"10.1016\/S2666-5247(21)00175-0","article-title":"Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis","volume":"2","author":"Ismail","year":"2021","journal-title":"Lancet Microbe"},{"key":"2025010309474865500_dkae405-B39","doi-asserted-by":"publisher","first-page":"16526","DOI":"10.1074\/jbc.M113.538959","article-title":"Crystal structure of the transcriptional regulator Rv0678 of Mycobacterium tuberculosis","volume":"289","author":"Radhakrishnan","year":"2014","journal-title":"J Biol Chem"},{"key":"2025010309474865500_dkae405-B40","volume-title":"Catalogue of Mutations in Mycobacterium tuberculosis Complex and Their Association with Drug Resistance","author":"WHO","year":"2021"},{"key":"2025010309474865500_dkae405-B41","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S2666-5247(23)00002-2","article-title":"Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis","volume":"4","author":"Sonnenkalb","year":"2023","journal-title":"Lancet Microbe"},{"key":"2025010309474865500_dkae405-B42","doi-asserted-by":"publisher","first-page":"e00292-19","DOI":"10.1128\/AAC.00292-19","article-title":"In vitro study of stepwise acquisition of rv0678 and atpE mutations conferring bedaquiline resistance","volume":"63","author":"Ismail","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309474865500_dkae405-B43","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/jac\/dkaa136","article-title":"Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid","volume":"75","author":"Kadura","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2025010309474865500_dkae405-B44","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","article-title":"The genome sequence archive family: toward explosive data growth and diverse data types","volume":"19","author":"Chen T","year":"2021","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"2025010309474865500_dkae405-B45","doi-asserted-by":"publisher","first-page":"D27","DOI":"10.1093\/nar\/gkab951","article-title":"Database resources of the National Genomics Data Center, China National Center for Bioinformation in 2022","volume":"50","author":"Partners C-NMa","year":"2022","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/1\/262\/60583778\/dkae405.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/1\/262\/60583778\/dkae405.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T09:48:14Z","timestamp":1735897694000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/80\/1\/262\/7889090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,11,11]]},"published-print":{"date-parts":[[2025,1,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkae405","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,11,11]]}}}